[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Propedix, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100611829",false,"NCT07245667","Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study","Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis","Inclusion Criteria:\n\n* Male or female, aged 16 or above\n* Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)\n* Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)\n* Signed and dated informed consent form\n* Willingness to comply with study protocol and availability for the duration of the study\n\nExclusion Criteria:\n\n* Diagnosis of moccasin-type tinea pedis\n* Presence of serous exudate or pus\n* Treatment with a topical antifungal in the past 2 weeks\n* Treatment with a systemic antifungal in the past 4 weeks\n* Concurrent immunosuppressive or antimicrobial therapy\n* Liver disease\n* Pregnancy or breastfeeding\n* Use any other antifungal therapy during trial or within three months of starting the trial\n* Known hypersensitivity to any ingredients of trial agents\n* Patients with a current diagnosis of diabetes or neuropathy",true,"ALL","16 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).",[26],"Tinea Pedis",[28,29],"tinea pedis","athletes foot","RECRUITING","2025-11-23",{"date":33,"type":34},"2025-11-28","ACTUAL",{"date":36,"type":34},"2024-12-30",{"date":38,"type":20},"2026-02",{"name":40,"class":41},"Propedix, Inc.","INDUSTRY",2,""]